Advertisement
Canada markets close in 3 hours 41 minutes

  • S&P/TSX

    21,982.37
    +96.99 (+0.44%)
     

  • S&P 500

    5,103.41
    +54.99 (+1.09%)
     

  • DOW

    38,257.86
    +172.06 (+0.45%)
     

  • CAD/USD

    0.7315
    -0.0008 (-0.11%)
     

  • CRUDE OIL

    84.08
    +0.51 (+0.61%)
     

  • Bitcoin CAD

    86,861.08
    -667.16 (-0.76%)
     

  • CMC Crypto 200

    1,322.53
    -74.01 (-5.30%)
     

  • GOLD FUTURES

    2,348.20
    +5.70 (+0.24%)
     

  • RUSSELL 2000

    1,997.86
    +16.74 (+0.84%)
     

  • 10-Yr Bond

    4.6710
    -0.0350 (-0.74%)
     

  • NASDAQ

    15,930.63
    +318.87 (+2.04%)
     

  • VOLATILITY

    15.31
    -0.06 (-0.39%)
     

  • FTSE

    8,139.83
    +60.97 (+0.75%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Stocks in play: PharmaCielo Ltd.

Baystreet.ca

Has signed a United States sales agreement with an established multi-state distributor, General Extract LLC. According to the non-exclusive Agreement, PharmaCielo will provide the distributor with bulk medicinal CBD isolate meeting the purity requirements of the 2018 USA Farm Bill, for sale in multiple states including California and Colorado. The Agreement addresses the balance of 2019 and allows for both renewal and volume expansion in 2020 based on market demand. PharmaCielo Ltd. shares V.PCLO are trading up $0.12 at $5.70.